Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in...

TL;DR

Summary:
- This study investigates the role of the enzyme G6PC1 in the liver, specifically how its regulation influences glucose production and metabolic homeostasis.
- The research elucidates a novel signaling mechanism involving the protein PKA, which modulates G6PC1 activity to prevent excessive hepatic glucose output, offering potential therapeutic targets for managing type 2 diabetes.

Like summarized versions? Support us on Patreon!